Gillette India Limited has informed the exchange about the Outcome of the Board Meeting held on July 30, 2026

Gillette India Limited CIN: L28931MH1984PLC267130 Regd. Office P&G Plaza, Cardinal Gracias Road, Chakala, Andheri (E), Mumbai - 400099 Tel: (91-22) 6958 6000 Fax: (91-22) 6958 7337 Website: in.pg.com July 30, 2026 To, To, The Corporate Relations Department The Listing Department The BSE Limited The National Stock Exchange of India Limited Department of Corporate Services Exchange Plaza, Plot No. C/1, G Block, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400001 Mumbai – 400051 Ref:- Scrip Code:- 507815 Ref:- NSE Symbol:- GILLETTE Dear Sir/Madam, Sub:- Outcome of Board Meeting held on July 30, 2026 We are pleased to inform you that at a meeting of the Board of Directors of the Company held today (started at 11:13 A.M and concluded at 11:33 A.M), the Unaudited Financial Results for the quarter ended June 30, 2026 were approved. We are enclosing herewith the following: a. Unaudited Financial Results for the quarter ended June 30, 2026; b. Limited Review Report in respect of the Unaudited Financial Results for the quarter ended June 30, 2026 furnished by Statutory Auditors of the Company. Kindly take the same on record and oblige. Thanking you, Yours faithfully, For Gillette India Limited Flavia Machado Company Secretary KALYANIWALLA & MISTRY LLP CHARTERED ACCOUNTANTS REVIEW REPORT TO THE BOARD OF DIRECTORS GILLETTE INDIA LIMITED 1. We have reviewed the accompanying Statement of Unaudited Financial Results of GILLETTE INDIA LIMITED ("the Company'') for the quarter ended June 30, 2026, and the notes thereon, ("the Statement") attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, duly initialled by us for identification. This Statement, which is the responsibility of the Company's Management, has been reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on July 30, 2026, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 'Interim Financial Reporting' ('Ind AS 34'), prescribed under Section 133 of the Companies Act, 2013 (''the Act") read with relevant Rules issued thereunder, as applicable and other accounting principles generally accepted in India. Our responsibility is to issue a report on the Statement based on our review. 2. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the Entity", issued by the Institute of Chartered Accountants of India. This Standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review is limited primarily to inquiries of company personnel and analytical procedures applied to financial data and thus provides Jess assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. 3. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with applicable accounting standards and other recognized accounting practices and policies, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement. 4. Attention is drawn to the fact that the figures for the three months ended March 3 I, 2026, as reported in the Statement, are the balancing figures between the audited figures in respect of the full previous financial year and the published year to date figures up to the end of the third quarter of the previous financial year, which have been reviewed and not subjected to audit by us. For KALYANIWALLA & MISTRY LLP CHARTERED ACCOUNTANTS Finn Regn. No.: 104607W / W100166 Roshni R Marfatia PARTNER M. No.: 106548 UDIN: 26106548ERIWHW9819 Mumbai: July 30, 2026. LLP IN : AAH • 3437 REGISTERED OFFICE : ESPLANADE HOUSE, 29, HAZARIMAL SOMANI MARG, FORT, MUMBAI 400 ooi TEL.: (91) (22) 6158 6200, 6158 7200 FAX: (9>) (22) 6>58 6275 Highly Restricted Gillette India Limited CIN; L28931MH1984PLC267130 Regd. Olfke: P&G Plaza, C.rdinal Gra.ciaa Road, Chakala, Andhori (EJ, Mumbai. 400099 Tel; (91-22) 6958 &000 Fax: (91-22) 6958 7337 W.baite: In.pg.com ~in Lakhs) STATEMENT OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2026 (1} (2} (3) (4) Three Months Prece<ling Corresponding Previous Year Particulars Ended Three Monlhs Three Months Ended 30th June 2026 Ended Ended 31sl Ma,ch 2026 31st Mafch 2026 30th June 2025 {Unaudited) (Audited} (Unaudited} (Audited) (Refer note 4 below) 1 Revenue from operations 78302 79200 70672 309 953 2 OthQf income 522 498 668 2789 3 Total income (1+2J 78824 79698 71340 312742 4 Expenses (al Cost of materials consumed 18770 17246 17697 73081 (b) Purchases of stock-ifHrade {Traded goods) 9455 12446 8157 44642 (c} Changes in inventories of finished goods, stock•in-lrade and work-in-progress 1109 ( 686) ( 4250) ( 4285) (d) Employee benefits expense 6117 4581 4889 21 969 !el Finance costs 102 329 104 1 206 (I) Deprectatlon and amortization expense 1 797 1891 2 046 7854 (g) Advertising & sales promo110n expenses 10 332 8597 13637 43759 (h) Other expenses 9740 9289 9517 36482 Total oxponses 57422 53693 51797 224 708 5 Profit before tax (3-4) 21402 26005 19543 88034 6 Income tax expense (a) Current tax 5594 6 707 5164 23126 { (b c)) D Pre if oe fr yre ed rl a tax x adjustments ( 137) ( 1-90) ( 5 689 6) Income tax expense 5457 6754 4974 22803 7 Profit for the period (5-6) 15945 19 251 14569 65431 8 Other comprehensive income/[loss) Items thal will not be reclassified lo profil or loss: Re--measurement of Iha defined benefit plans 167 691 { 156) 666 Income tax effect on above { 421 ( 174) 39 ( 168) Total other comprehensive income/(loss) 125 517 ( 117J 498 9 Total comprehensive income for the period [7+8) 16070 19788 14452 65929 10 Paid-up equity share capital (Face Valuer 10 per Equity Share I 3259 3 259 3259 3 259 11 Other Equity 91 384 12 Earnin11s per share (Face value oft 10/· per equity shareJ (not annualised): (a) Basic (int) 48.93 59.08 44.71 200.80 (b) Diluted ( int) 48.93 59.08 44.71 200.80 See accomoanvino notes to the Financial Results i\ MUMBAI); I Highly Restricted Segment wise Revenue, Results, Assets and Liabilities under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: ~( inlakhsl (1) (2) (3) (4) Three Months Preceding Corresponding Previous Year Particulars Ended Three Months Three Months Ended 30th June 2026 Ended Ended 31st March 2026 31st March 2026 30th June 2025 (Unaudited) (Audited) (Unaudited) (Audited) (Refer note 4 below) 1.Segment Revenue -Grooming 62 865 65 326 57 693 2 54 318 -Oral Care 15437 13 874 12979 55635 Total Income from Operations 78302 79200 70672 309953 2.Segment Resufts (ProfiV(Loss)) before finance costs and tax -Grooming 17 345 22 997 15 353 75298 -Oral Care 3771 2856 3681 10858 Total Seamen! Results 21116 25853 19 034 86156 Less: Finance costs ( 102) ( 329) ( 104) ( 1206) Add/lless): UnaHocabla Income net of Unallocable Exoenditure 388 481 613 3084 Total Profit Before Tax 21402 26005 19543 88034 3. Segment assets -Grooming 103844 113052 107073 113052 -Oral Ca,e 11182 13257 11 603 13257 Total Seamen! Assets 115 026 126309 118 676 126309 - Unallocaled C0<1)()(ate Assets 94428 60838 93875 60838 To tat Assets 2 09454 187147 212 551 1 87 147 4. Segment liabilities -Grooming 64991 60772 62 786 60772 -OralCa,e 14 628 13355 12 351 13355 Total Seamen! Liabilities 79 619 74127 75 137 74127 - Unallocated Coma,ate IJabol.tJes 18993 18377 20524 18377 Total Liabilities 98 612 [Showing first 8,000 characters — download PDF for full document]